Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein
Jan‐Philipp Mallm, Christian Bundschuh, Hee-Young Kim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 20

Showing 20 citing articles:

The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines
Mehrdad Mohammadi, Mohammad Shayestehpour, Hamed Mirzaei
The Brazilian Journal of Infectious Diseases (2021) Vol. 25, Iss. 4, pp. 101606-101606
Open Access | Times Cited: 126
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
Louise Benning, Christian Morath, Marie Bartenschlager, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 7, pp. 1873-1883
Open Access | Times Cited: 46
Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
Deepali Gupta, Priyanka Sharma, Mandeep Singh, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 24, pp. 7967-7989
Open Access | Times Cited: 51
Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A
Maja Klevanski, Heeyoung Kim, Mike Heilemann, et al.
Antiviral Research (2024) Vol. 225, pp. 105856-105856
Open Access | Times Cited: 8
Antibody escape and global spread of SARS-CoV-2 lineage A.27
Tamara Kaleta, Lisa Kern, Samuel L. Hong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 28
Follow-up investigation and detailed mutational characterization of the SARS-CoV-2 Omicron variant lineages (BA.1, BA.2, BA.3 and BA.1.1)
Qussai Abbas, Aleksey V. Kusakin, Kinda Sharrouf, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 20
Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid
Louise Benning, Christian Morath, Tessa Kühn, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients
Louise Benning, Katrin Klein, Christian Morath, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers
Louise Benning, Christian Morath, Marie Bartenschlager, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 7, pp. 1024.e7-1024.e12
Open Access | Times Cited: 16
Evolution of SARS-CoV-2 in the Rhine-Neckar/Heidelberg Region 01/2021 – 07/2023
Christian Bundschuh, Niklas Weidner, Julian Klein, et al.
Infection Genetics and Evolution (2024) Vol. 119, pp. 105577-105577
Open Access | Times Cited: 2
Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
Laura Ciuffreda, José M. Lorenzo-Salazar, Julia Alcoba-Flórez, et al.
Journal of Infection (2021) Vol. 83, Iss. 5, pp. 607-635
Open Access | Times Cited: 14
A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic
Priyanka Singh, Sanjay Singh Negi, Anudita Bhargava, et al.
Archives of Medical Research (2022) Vol. 53, Iss. 6, pp. 574-584
Open Access | Times Cited: 8
Neutralizing Antibodies Against SARS-CoV-2 Variants Induced by Natural Infection or Vaccination: A Systematic Review and Individual Data Meta-Analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 10
Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy
Maximilian Töllner, Claudius Speer, Louise Benning, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1739-1739
Open Access | Times Cited: 7
Rise and Fall of SARS-CoV-2 Lineage A.27 in Germany
Sébastien Calvignac‐Spencer, Matthias Budt, Matthew R. Huska, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1491-1491
Open Access | Times Cited: 9
Comparative Analysis of B.1.617.2 (Delta) Variant of SARS-CoV-2
Mohd Fardeen Husain Shahanshah, Saloni JAİN, Bhawna Sharma, et al.
Journal of Microbiology and Infectious Diseases (2022), pp. 38-51
Open Access | Times Cited: 1
Antibody escape and global spread of SARS-CoV-2 lineage A.27
Tamara Kaleta, Lisa Kern, Samuel L. Hong, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
Laura Ciuffreda, José M. Lorenzo-Salazar, Julia Alcoba-Flórez, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Evolution of SARS-CoV-2 in the Rhine-Neckar/Heidelberg Region 01/2021 – 07/2023
Christian Bundschuh, Niklas Weidner, J. Klein, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
Laura Ciuffreda, José M. Lorenzo-Salazar, Julia Alcoba-Flórez, et al.
Research Square (Research Square) (2021)
Closed Access
Page 1

Scroll to top